Angela Haczku

Title: Angela Haczku: Innovator in Asthma Treatment

Introduction

Angela Haczku is a notable inventor based in Davis, CA (US), recognized for her contributions to the field of asthma treatment. With a total of 2 patents, her work focuses on innovative methods and compositions aimed at improving the lives of individuals suffering from respiratory conditions.

Latest Patents

Haczku's latest patents include significant advancements in the treatment of asthma. One of her inventions, titled "Effects of LGM2605 on a primate model of asthma," provides compositions and methods for treating asthma in subjects in need. This invention involves administering chemically synthesized secoisolaricirecinol diglucoside (SDG), particularly a racemic mixture of the SDG (LGM2605), along with its stereoisomers, metabolites, and analogs. Additionally, the patent outlines methods for treating or preventing ozone-induced damage in affected subjects.

Career Highlights

Throughout her career, Angela Haczku has worked with prestigious institutions, including the University of Pennsylvania and the University of California. Her research and innovations have made a significant impact in the medical field, particularly in respiratory health.

Collaborations

Haczku has collaborated with various professionals in her field, including Melpo Christofidou-Solomidou, who has contributed to her research endeavors.

Conclusion

Angela Haczku's innovative work in asthma treatment showcases her dedication to improving health outcomes for individuals with respiratory issues. Her patents reflect a commitment to advancing medical science and providing effective solutions for patients in need.